As sole US heparin provider, APP reassures on Chinese supply chain
This article was originally published in Scrip
Executive Summary
APP Pharmaceuticals– the sole provider of heparin multi-dose vials in the US is having to work around worldwide supply issues for crude heparin, and contend with soaring prices for that starting material.